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Abstract
Flavonoids have attracted considerable attention in relation to their effects upon health. 8-Prenylnaringenin (8-PN) is found
in the common hop (Humulus lupulus) and assumed to be responsible for the health impact of beer consumption. We
wanted to clarify the effects of prenylation on the physiological functions of dietary flavonoids by comparing the effects of
8-PN with that of intact naringenin in the prevention of disuse muscle atrophy using a model of denervation in mice.
Consumption of 8-PN (but not naringenin) prevented loss of weight in the gastrocnemius muscle further supported by the
lack of induction of the protein content of a key ubiquitin ligase involved in muscle atrophy, atrogin-1, and by the activation
of Akt phosphorylation. 8-PN content in the gastrocnemius muscle was tenfold higher than that of naringenin. These results
suggested that, compared with naringenin, 8-PN was effectively concentrated into skeletal muscle to exert its preventive
effects upon disuse muscle atrophy. It is likely that prenylation generates novel functions for 8-PN by enhancing its
accumulation into muscle tissue through dietary intake.
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Introduction
Flavonoids are plant secondary metabolites derived from
malonyl-CoA and p-coumaroyl-CoA. Flavonoids have attracted
considerable attention in relation to their effects upon human
health [1,2]. In prenylflavonoids, the C5 isoprenoid group is
substituted in the diphenylpropane structure. Prenylflavonoids
such as prenylchalcones, prenylflavones, prenylflavonols and
prenylflavanones are distributed mainly in the roots, leaves, and
seeds [3,4]. In particular, prenylflavanones occur mostly in
Legmuminosae, Moraceae and Asteraceae [3]. Recent studies
have suggested that prenylflavonoids exert powerful biological
functions. For example, the prenylflavonol icaritin was shown to
prevent cell growth by inducing cell-cycle arrest in carcinoma cells
[5]. Prenylflavanones extracted from the roots of Sophora flavescens
were found to possess antibacterial and anti-androgen activities
[6]. Prenylflavones from Psoralea corylifolia and Mori Cortex Radics
suppressed the production of nitric oxide in nerve cells [7,8].
Prenylation has been demonstrated to enhance the estrogenic
activity of (1) naringenin [9] and the tyrosinase activity of luteolin
[10]. These observations suggest the superiority of prenylflavo-
noids to non-prenylflavonoids within in vitro cell culture systems.
However, little is known about the effect of prenylation on the
physiological functions and bioavailability of dietary flavonoids in
vivo. Recently, Sasaki et al. [11] discovered flavonoid prenyltrans-
ferase from the legume Sophora flavescens, and successfully under-
took molecular cloning of this enzyme. That report urged us to
explore a novel physiological function of prenylflavonoids because
various prenylflavonoids seem to be readily prepared using this
enzyme.
A prenylchalcone, (2) xanthohumol, is the principal flavonoid in
the common hop (Humulus lupulus) [12]. In beer production,
xanthohumol undergoes a ring-closing reaction, resulting in the
formation of (3) isoxanthohumol [13]. This prenylflavonoid is
further converted to (4) 8-prenylnaringenin (8-PN) by demethyl-
ation of the methoxy group attached to the diphenylpropane
structure through the hepatic CYP450 reaction [14] and
microflora metabolism in humans [15,16] (Figure 1). Therefore,
humans may ingest 8-PN as a metabolite of isoxanthohumol as
well as a hop ingredient in beer. Animal studies have revealed that
a prenylflavanone, 8-PN, exerts beneficial effects against hot
flushes [17] and bone loss [18]. Prenylation at the 8-position of
naringenin was found to be responsible for the enhanced
estrogenic activity of 8-PN in a rat serotonergic cell line [19].
These findings suggested that prenylation plays an important part
in the physiological function of dietary flavonoids. Nevertheless,
how prenylation enhances the physiological function of dietary
flavonoids in the body is not known.
The aim of the present study was to compare the effect of 8-PN
(prepared by chemical synthesis [20]) with that of non-prenylated
naringenin (which is commonly found in grapefruit and sour
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oranges [21]) on disuse muscle atrophy using a denervation model
in mice. This was done because estrogenic activity has been
reported to be associated with muscle maintenance by activating
Akt phosphorylation [22,23]. Denervation induces expression of
atrogin-1 (a skeletal muscle-specific ubiquitin ligase) and mice
deficient in atrogin-1 are resistant to muscle atrophy caused by
denervation [24,25]. Phosphorylation of Akt has been suggested to
suppress the expression of atrogin-1 by preventing activation of the
transcription factor for atrogin-1: the Forkhead box-containing, O
subfamily (FoxO) family of transcription factors [26,27,28].
We also examined the concentrations of 8-PN and naringenin in
blood plasma and target muscle tissues to evaluate the effect of
prenylation on the bioavailability and liability for transport to the
target site in the prevention of muscle atrophy by dietary
flavonoids. The results of the present study were expected to be
helpful in estimation of the effects of brewery products on human
health.
Materials and Methods
Materials
Naringenin was obtained from Tokyo Chemical Industry,
Tokyo, Japan). 8-PN was synthesized by our research team [20].
Dried H. lupulus powder was obtained from Nippon Funmatsu
Yakuhin (Osaka, Japan).
Animal Experiments
All experimental protocols were in accordancewith the guidelines
for the care and use of laboratory animals set by theGraduate School
of the Institute of Health Biosciences, the University of Tokushima
(Tokushima, Japan). The protocol was approved by the Committee
on Animal Experiments of the University of Tokushima (permit
number: 11013). All surgery was undertaken under anesthesia using
sodiumpentobarbital or ether. All efforts weremade tominimize the
suffering of the animals.
Figure 1. Conversion of xanthohumol to 8-prenylnaringenin (8-PN).
doi:10.1371/journal.pone.0045048.g001
8-Prenylnaringenin Prevents Disuse Muscle Atrophy
PLOS ONE | www.plosone.org 2 September 2012 | Volume 7 | Issue 9 | e45048
Experiment I: Estimation of Loss in Muscle Weight
Seven-week-old male C57/BL6 mice (Japan SLC, Shizuoka,
Japan) were housed in a room maintained at 2361uC on a 12-h
light–dark cycle. They were allowed free access to a commercial
diet (AIN-93M; Oriental Yeast Company, Tokyo, Japan) and
water. The sciatic nerve in the right leg of each mouse was cut to
induce immobilization, and then disuse muscle atrophy provoked
in the gastrocnemius muscle (GM) (i.e., denervation). Sham
surgery was undertaken in the left leg of each mouse to obtain
control muscle. The GM was collected and its weight measured 2,
4, and 6 days later.
Experiment II: Preventive Effects of Continuous Intake of
8-PN and Naringenin on Disuse Muscle Atrophy
8-PN or naringenin (5.6 mmol/kg diet) was mixed with AIN-
93M and given to mice. Cellulose content was reduced to adjust
for the composition of other nutrients. Denervation was carried
out on day 18. The GM was collected 4 or 6 days later. The level
of atrophy in the GM was calculated to be the ratio of the weight
of denervated muscle to the weight of control muscle in each
mouse. Samples of the GM were stored at –80uC under N2 gas
until high-performance liquid chromatography (HPLC) analyses.
The GM was immediately used for the measurement of protein
and water contents.
Experiment III: Accumulation of 8-PN in the GM and
Plasma after Dietary Consumption
Experimental conditions (mice, feeding, denervation) until
sample collection were identical to those described in experiment
II. Blood collection and body reflux was performed before
collection of the GM. Plasma was isolated from blood by
centrifugation at 9,0006g for 10 min at 4uC. Samples of the
GM and plasma were stored at –80uC under N2 gas until HPLC
analyses.
Experiment IV: Pharmacokinetics of 8-PN and Naringenin
Seven-week-old male C57/BL6 mice (Japan SLC) were housed
in a room maintained at 2361uC on a 12-h light–dark cycle. They
were allowed free access to a commercial diet (AIN-93M) and
water for 1 week. Before administration, they were deprived of
food for 18 h, but had free access to water. 8-PN or naringenin
dissolved in propylene glycol was administered (50 mg/kg body
weight (bw)) to mice by a gastric feeding tube. Blood was collected
0.25, 0.5, 1, 2, 4, 8, and 24 h after administration. Plasma was
isolated by centrifugation at 9,0006g for 10 min at 4uC and stored
at –80uC under N2 gas until use.
Experiment V: Preventive Effect of H. lupulus on Disuse
Muscle Atrophy
Dried H. lupulus powder was mixed (5% w/w) with AIN-93M
and given to mice. Cellulose content was reduced to adjust for the
composition of other nutrients. Denervation was carried out on
day 14. The GM was collected 4 days later. The level of atrophy of
the GM was calculated to be the ratio of the weight of denervated
muscle to the weight of control muscle in each mouse.
Measurement of Water Content and Protein
Concentration in the GM
Water content in muscle was determined by measuring dry
muscle weight [30]. About 50 mg of the wet mass of the GM was
weighed, subjected to a drying heater at 70uC, and weighed every
60 min until a constant dry weight was obtained.
For the measurement of protein concentration, the GM was
homogenized on ice in buffer containing 50 mM HEPES
(pH 7.4), 4 mM ethylene glycol tetra-acetic acid (EGTA),
20 mM ethylene diamine tetra-acetic acid (EDTA), 0.1% Triton
X-100, a protease inhibitor tablet (Complete; Roche Applied
Science, Indianapolis, IN, USA) and a phosphatase inhibitor tablet
(PhosSTOP; Roche Applied Science). Samples were incubated on
ice for 1 h with shaking every 10 min. Samples were centrifuged at
20,0006g for 20 min at 4uC. The supernatant was collected and
protein concentration determined in triplicate using the Bradford
method [31].
Western Blotting
The GM was homogenized on ice in buffer containing 50 mM
Tris-HCl (pH 7.5), 150 mM NaCl, 5 mM EDTA, 1% Triton X-
100, a protease inhibitor tablet (Complete) and a phosphatase
inhibitor tablet (PhosSTOP). Samples were incubated on ice for
1 h with shaking every 10 min. Samples were centrifuged at
20,0006g for 20 min at 4uC. Supernatants were collected as whole
protein lysates. The protein concentration was determined in
triplicate using the Bradford method [31]. Protein lysates were
separated by 10% sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE). Proteins were transferred onto
polyvinylidene difluoride membranes (GE Healthcare Piscataway,
NJ, USA) followed by blocking of non-specific binding with a
commercial blocking buffer (Blocking-One, Nacalai Tesque,
Kyoto, Japan) for 1 h. Membranes were incubated with anti-
atrogin-1 antibody (1:1,000 dilution; ECM Biosciences, Versailles,
KY, USA) anti-pAKTser473 antibody (1:500; Cell Signaling
Technology, Danvers, MA, USA), anti-pAKTthr308 antibody
(1:500; Cell Signaling Technology), anti-glyceraldehyde 3-phos-
phate dehydrogenase (GAPDH) antibody (1:5,000; Cell Signaling
Technology), and ant-Akt antibody (1:1,000; Cell Signaling
Technology) for 1 h at room temperature. After washing with
Tris-buffered saline containing 0.05% Tween 20 (TBST), mem-
branes were incubated with peroxidase-labeled secondary anti-
body for 1 h. After washing three times with TBST (for pAkt) or
phosphate-buffered saline containing 0.05% Tween 20 (PBST) (for
other proteins), immunocomplexes were visualized using a
Chemiluminescence Detection Kit (ECL Prime, GE Healthcare
BioScience) and analyzed by Image J software (National Institutes
of Health, Bethesda, MD, USA).
Analyses of 8-PN and Naringenin in the GM
Each GM was homogenized with phosphate-buffered saline
(PBS; 9-times volume of the weight of GM) using a Teflon
Homogenizer (As One, Osaka, Japan) on ice. For analyses of total
8-PN or naringenin (conjugated metabolites plus aglycone) in the
Table 1. Protein and water content in the GM.
Diet Condition
Protein content
(mg/g GM)
Water content
(%, w/w)
Control Sham 61.762.4 76.260.29
Denervation 65.460.9 75.860.52
PN Sham 63.161.6 76.360.52
Denervation 66.962.6 77.360.37
N Sham 59.162.1 76.960.71
Denervation 62.961.6 77.960.39
Data are the mean 6 S.E. There was no significant difference upon analyses by
the Tukey multiple comparison test with one-way ANOVA (p,0.05).
doi:10.1371/journal.pone.0045048.t001
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Figure 2. 8-PN can prevent disuse muscle atrophy by enhancing Akt phosphorylation. (a) Muscle atrophy induced by denervation. The
weight of the GM was measured after denervation for the indicated period. Open bar: sham leg (left); closed bar: denervated leg (right). Data are the
mean 6 S.E (n = 4). Asterisks indicate significant differences between sham and the denervated leg (Student’s t-test, p,0.007). (b) Effect of dietary
intake of 8-PN or naringenin on muscle atrophy. Mice consumed each flavonoid-mixed diet for 18 days, and denervation was then carried out. After 4
(black bar) or 6 (white bar) days, the level of atrophy in the GM was calculated as the ratio of the weight of denervated muscle to the weight of sham
muscle in each mouse. Data are the mean 6 S.E (n = 4). C: control-diet group, 8-PN: 8-PN-containing diet group. Asterisks indicate significant
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GM, muscle homogenates were mixed with 50 mM ascorbic acid
(0.2-times volume of PBS) and 100 U/0.1 mL b-glucuronidase
type H-1 solution (final concentration: 9 units/mg GM; Sigma–
Aldrich, St Louis, MO, USA) and incubated for 2 h at 37uC.
Hydrolysates were extracted three times with the same volume of
ethyl acetate and evaporated using a Centrifugal Evaporator
(CVE-100, Tokyo Rikakikai, Tokyo, Japan). Extracts were
dissolved in 150 mL (for 8-PN) or 30 mL (for naringenin) of
methanol containing 0.5% phosphoric acid. Twenty microliters of
the sample were injected into the HPLC electrochemical detection
system (700 mV; Coulochem III, ESA, Cambridge, MA, USA)
equipped with a Cadenza 3-mm CD-C18 HPLC column
(15064.6 mm; Imtakt, Hampshire, UK). Separation of com-
pounds was carried out by gradient elution. Solvent A was 0.5%
phosphoric acid, and solvent B was acetonitrile containing 0.5%
phosphoric acid. For 8-PN detection, the gradient program was: 0
min, 30% B; 0–15 min, linear gradient to 40% B; 15–35 min,
linear gradient to 60% B; 35–36 min, linear gradient to 100% B;
36–39 min, 100% B; 39–40 min, linear gradient to 30% B; flow
rate, 1 mL/min. For naringenin detection, the gradient program
was: 0 min, 15% B; 0–10 min, linear gradient to 33% B; 15–
25 min, linear gradient to 60% B; 25–26 min, linear gradient to
100% B; 26–30 min, 100% B; 30–31 min, linear gradient to 15%
B; 31–35 min, 15% B; flow rate, 1 mL/min.
Cell Culture and Sample Preparation for Cellular Uptake
The mouse myoblast cell line C2C12 (American Type Culture
Collection, Rockville, MD, USA) was maintained in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% fetal
bovine serum, 100 U/mL penicillin, 100 mg/mL streptomycin,
and 2 mM L-glutamine at 37uC in a humidified atmosphere
containing 5% CO2. Cells seeded on a 60-mm dish were cultured
until confluent. Differentiation was initiated with 2% horse serum
containing DMEM for 96 h. Cells were incubated with 10 mM 8-
PN or naringenin. After incubation, cells were washed twice with
ice-cold PBS and scraped from the dish. The protein concentra-
tion of cell suspensions was measured using the Bradford assay
[31]. After centrifugation (9,0006g for 10 min at 4uC) 8-PN and
naringenin were extracted three times in ethyl acetate by
sonication for 1 min using an Astrason XL2020 Ultrasonic
Processor (Heat Systems-Ultrasonic, Farmingdale, NY, USA) at
level 10. Before extraction, 100 pmol of pentamethyl quercetin
(for 8-PN) or kaempferol (for naringenin) was added to cell
suspensions as the internal standard. After centrifugation (9,0006g
for 10 min at 4uC), supernatants were collected, evaporated under
N2 gas, and dissolved in 50 mL of methanol containing 0.5%
phosphoric acid. Twenty microliters of the sample were injected
into the HPLC–UV system.
Sample Preparation for the Determination of Plasma
Concentration
To analyze the concentration of metabolites and/or aglycone,
plasma (10 mL) was incubated with 100 U of b-glucuronidase type
H-1 (which possessed b-glucuronidase and sulphatase activity) in
0.1 M sodium acetate buffer, pH 5.0 (90 mL) and 50 mM ascorbic
acid (20 mL) for 45 min. To measure the aglycone concentration,
plasma without deconjugation treatment was applied to the
experiment. Then, 100 pmol of pentamethyl quercetin (for 8-
PN) or kaempferol (for naringenin) was added to samples as the
internal standard. The liberated aglycone was extracted with ethyl
acetate and evaporated using the Centrifugal Evaporator, and
dissolved in 75 mL of methanol containing 0.5% phosphoric acid.
A total of 25 mL of the sample was injected into the HPLC–UV
detection system.
Calculation of ClogP Values
ClogP values of 8-PN and naringenin were calculated using
ChemBioDraw Ultra ver11.0 (PerkinElmer, Waltham, MA, USA).
Determination of Cellular Uptake and Plasma
Concentration
8-PN and naringenin were analyzed by HPLC–UV detection
using a lmax value of 292 nm (SPD-10AV; Shimadzu, Tokyo,
Japan) equipped with a TSK-gel ODS-80Ts HPLC column
(15064.6 mm; Tosoh, Tokyo, Japan). In the mobile phase, solvent
A was 0.5% phosphoric acid, and solvent B was methanol
containing 0.5% phosphoric acid. For 8-PN detection, B was 65%.
For naringenin detection, B was 55%. The flow rate was 1.0 mL/
min.
Statistical Analyses
Data are the mean 6 SE. Data of protein content and water
content in the GM, effect of dietary intake on 8-PN or naringenin
on muscle atrophy and phosphorylation of Akt and atrogin-1 were
analyzed by one-way ANOVA with the Tukey multiple compar-
ison test (p,0.05). Data of accumulation of 8-PN or naringenin in
the GM and plasma were analyzed by two-way ANOVA with the
Tukey multiple comparison test (p,0.05). Data of the effect of
denervation on muscle atrophy, effect of H. lupulus on muscle
atrophy as well as pharmacokinetic parameters of 8-PN and
naringenin were analyzed by the two-sided Student’s t-test
(p,0.05).
Results
Preventive Effects of 8-PN on Disuse Muscle Atrophy
Denervation was initiated in the right legs of mice to induce loss
of muscle weight in this model of disuse muscle atrophy [32]. The
body weight of mice did not change #6 days after denervation
(data not shown). In contrast, the weight of the GM of the
denervated leg was significantly decreased 4 days and 6 days after
denervation (Figure 2a). Next, mice were fed a diet containing 8-
PN or naringenin (5.6 mmol flavonoid/kg diet) for 18 days before
denervation. After denervation, these mice were fed the same diet
for an additional 4 days or 6 days. Collection of the GM and blood
was carried out just after the end of feeding period (22 days or 24
days). No significant difference was observed in food intake among
the control-diet group, 8-PN-containing diet group or naringenin-
containing diet group during the experiment (daily consumption of
8-PN and naringenin was 1150–1250 nmol flavonoid/kg bw/day).
Figure 2b shows that 8-PN intake significantly suppressed the
denervation-induced loss in muscle weight, whereas naringenin
intake did not elicit such an effect. 8-PN and naringenin did not
attenuate the normal muscle mass (as % of body weight: control
differences to the control diet, which was analyzed by the Tukey multiple comparison test with one-way ANOVA (day 4: p= 0.0034; day 6: p= 0.041).
(c) Phosphorylation of Akt and atrogin-1 in the GM (which was collected on the 6th day after denervation) was detected by western blotting (upper)
and the density of each image analyzed (bottom). The black bar and white bar in left graph denote phosphorylated Akt and total Akt, respectively.
Data are the mean 6 S.E (n = 4). C: control-diet group, 8-PN: 8-PN-containing diet group. *Significant differences to the control diet-denervation
group (p0.05). #Significant differences to the control diet-sham group.
doi:10.1371/journal.pone.0045048.g002
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diet, 0.5760.01; PN diet, 0.5560.02; naringenin diet, 0.5860.01;
mean6SE, n= 4). With respect to water and protein contents,
there were no differences among all groups (Table 1). This finding
suggested that GM content was affected by 8-PN-intake as well as
denervation. These findings suggested that the prenyl group was
essential for 8-PN to exert its preventive effects on loss in muscle
weight.
The phosphorylation of residue ser-473 on Akt was measured to
ascertain whether 8-PN affects the balance of synthesis and
degradation of proteins in the inhibition of disuse muscle atrophy
(Figure 2c). The GM 6 days after denervation was applied for
western blotting. Total Akt expression was increased by denerva-
tion, and 8-PN intake showed no effect on the expression.
Although Akt phosphorylation was lowered by denervation, 8-PN
intake retained the phosphorylation status on Akt in denervated
muscle similar to that seen with sham muscle. No differences were
observed in GAPDH contents among all groups. We also detected
atrogin-1 in the GM. Denervation increased the level of atrogin-1.
Intake of 8-PN suppressed the atrogin-1 level in the denervated
muscle, suggesting that 8-PN intake delayed the development of
disuse muscle atrophy due to suppression of protein degradation.
Accumulation of 8-PN in the GM
The contents of 8-PN and naringenin in the GM were
determined by HPLC analyses with electrochemical detection
employing deconjugation treatment using b-glucuronidase (which
also had sulphatase activity) (Figures 3a–d). Peaks attributable to 8-
PN and naringenin appeared in the chromatogram of the extract
from the GM of mice fed diets containing 8-PN and naringenin,
respectively (Figures 3a and c). The retention times of these peaks
coincided with those for the standards of 8-PN and naringenin. No
peaks appeared at the corresponding retention times in the
chromatogram from mice fed the control diet (Figures 3b and d),
indicating that both flavonoids could accumulate in GM tissue by
oral intake of 8-PN and naringenin. Total amounts of flavonoids
(including both aglycones and their conjugated metabolites) could
be obtained by deconjugation of the extracts. The content of total
8-PN was 4.1260.56 nmol/g tissue (sham: without denervation)
and 6.4461.65 nmol/g tissue (with denervation). The content of
total naringenin was approximately tenfold lower than that of total
8-PN: 0.5660.04 nmol/g tissue (sham: without denervation) and
0.07060.02 nmol/g tissue (with denervation) (Figure 3e). We
further determined the contents of total flavonoids and their
aglycones in GM. To avoid blood contamination in the GM, we
carried out a body reflex before GM collection (experiment III).
The content of total 8-PN was 2.2660.33 nmol/g tissue (sham:
without denervation) and 3.0060.30 nmol/g tissue (with dener-
vation), and total naringenin was 0.2660.04 nmol/g tissue (sham:
without denervation) and 0.2360.02 nmol/g tissue (with dener-
vation) (Table 2). These results correlated with ones of the
experiment without a blood reflux under identical experimental
conditions (experiment II). These data suggested that prenylation
dramatically increased naringenin accumulation in skeletal mus-
cle. The content of the aglycone in GM was 0.3560.09 nmol/g
tissue (sham: without denervation) and 0.5060.06 nmol/g tissue
(with denervation) (Table 2). 8-PN accumulated in muscle tissue
mostly as its conjugated metabolites (although its aglycone also
accumulated at a low level).
Cellular Uptake of 8-PN in Mouse C2C12 Myotubes
We calculated the logarithm of the n-octanol/water partition
coefficient (i.e., ClogP) of 8-PN and naringenin as an index of their
hydrophobicity. We measured their uptake in mouse C2C12
myotubes to understand the reasons for the enhanced accumula-
tion by prenylation of naringenin. Prenylation increased the
hydrophobicity of naringenin because the ClogP of 8-PN and
naringenin were calculated to be 4.40 and 2.44, respectively. 8-PN
was incorporated into cells and/or associated with cellular
membranes at a much higher level than that observed in
naringenin, and remained in cells at a constant level until 24 h
of incubation (Figure 4). These results suggested that prenylation
of naringenin accelerated cellular uptake and inhibited the
excretion of naringenin from mouse C2C12 myotubes. The
resulting higher accumulation in the cell and/or association with
cell membranes could be correlated with an increase in
hydrophobicity due to prenylation.
Figure 3. Accumulation of 8-PN in the GM. (a)–(e): HPLC chromatograms for quantitative analyses of 8-PN or naringenin in the GM.
Chromatograms from mice fed an 8-PN-containing diet (a) and control diet (b). Chromatograms from mice fed a naringenin-containing diet (c) and
control diet (d). (a) and (b) were obtained by the analytical condition for 8-PN. (c) and (d) were obtained by the analytical condition for naringenin.
These analyses were undertaken by HPLC with electrochemical detection. (e) Contents of these flavonoids in the GM as determined by HPLC analysis.
Data are the mean 6 S.E (n = 4). Different letters indicate significant differences analyzed by the Tukey multiple comparison test with two-way
ANOVA (p= 0.00043).
doi:10.1371/journal.pone.0045048.g003
Table 2. Accumulation of 8-PN and naringenin in the GM and plasma after their dietary intake for 22 days.
8-PN Naringenin
GM Sham Denervation Sham Denervation
Total (nmol/g tissue, n = 7) 2.2660.33 a 3.0060.30a 0.2660.04b 0.2360.02b
Aglycone (nmol/g tissue, n = 6) 0.3560.09 0.5060.06 Not determined Not determined
Plasma
Total (mM, n= 7) 38.562.72 Not detected #0.025
Aglycone (mM, n = 7) 0.0660.01 Not detected #0.025
Blood was collected from mice fed flavonoid (5.6 mmol flavonoid/kg diet) for 22 days, and then total body reflux was carried out. The GM was collected after the reflux.
Plasma was prepared from the blood as described in the Materials and Methods section. Values of the total 8-PN and total naringenin indicate the sum of aglycone and
conjugated metabolites obtained by the HPLC analysis with deconjugation treatment. Amount of flavonoids was determined by HPLC analyses as described in the
Materials and Methods section. Data are the mean6 S.E. Different letters indicate significant differences upon analyses by the Tukey multiple comparison test with two-
way ANOVA (p=1.79610–9).
doi:10.1371/journal.pone.0045048.t002
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Blood Circulation of 8-PN in Mice
We investigated the plasma concentration and pharmacokinet-
ics of 8-PN and naringenin as an index of their bioavailability by
stomach intubation of these flavonoids in mice. Plasma concen-
trations of total 8-PN and total naringenin were obtained by
HPLC analyses with UV detection by deconjugation treatment. In
contrast with muscular accumulation, the values of the maximum
concentration achieved after dosing (Cmax) and area under the
curve (AUC) for 8-PN were significantly lower than those for
naringenin (Figure 5 and Table 3). This finding suggested that the
bioavailability of 8-PN was lower than that of naringenin for a
single dose. Nevertheless, the plasma concentration of 8-PN at
24 h (2.66l.5 mM) was higher than that seen with naringenin
(0.4660.28 mM) (Table 3). Moreover, the denervation model in
mice showed that 8-PN was present in plasma at 38.562.7 mM
mostly as its conjugated metabolites after mice were continuously
fed an 8-PN-containing diet for 22 days, whereas naringenin was
not detected in plasma under identical conditions (Table 2). This
result suggested that the plasma concentration of 8-PN was
increased gradually during continuous consumption, and was
different to that seen with non-prenylated naringenin.
Preventive Effects of H. lupulus Powder on Disuse Muscle
Atrophy
We used H. lupulus powder as a source of prenylated flavonoids
(including 8-PN). A mixed diet of H. lupulus powder (5% (w/w) in
the diet) was given to mice for 14 days before denervation. Dietary
intake of H. lupulus powder significantly suppressed the loss in
muscle weight (Figure 6).
Discussion
Disuse muscle atrophy is an urgent public healthcare issue in
aging societies because it is closely associated with the bedridden
state [33]. However, medications for the relief of this condition are
not available. Our previous study [1] revealed that periodic
injection of the flavonol-type flavonoid quercetin into the GM was
effective for prevention of the loss of muscle weight in mice that
underwent tail suspension (which was used as a model of disuse
muscle atrophy). Therefore, skeletal muscle is one of the target
tissues of flavonoids for exerting their pharmacological functions.
We first demonstrated that a prenylflavonoid prevented the loss of
function of the GM in mice that underwent sciatic denervation
(which is an alternative model of disuse muscle atrophy) (Figure 2).
The prenylflavonoid 8-PN was administered orally to mice by
mixing with the diet for 18 days before denervation. Hence, 8-PN
was assumed to prevent disuse muscle atrophy after intestinal
absorption and transport into the target muscle tissue. It can be
deduced that prenylation increases the bioavailability of a
continuously ingested flavonoid and promotes its accumulation
in muscle because the plasma concentration of total 8-PN and its
Figure 4. Cellular uptake of 8-PN in mouse C2C12 myotubes. Differentiated C2C12 cells seeded on 60-mm dishes were used. (a) 8-PN and (b)
naringenin (10 mM) were administered to the cells for the indicated time. Cell homogenates were prepared and then each flavonoid was extracted.
Amounts of flavonoids were determined by HPLC with UV detection. Data are the mean 6 S.E (n = 3).
doi:10.1371/journal.pone.0045048.g004
Table 3. Pharmacokinetic parameters of flavonoids after oral
administration of 8-PN and naringenin (50 mg/kg body
weight) in a single dose in mice.
Parameter 8-PN Naringenin
Cmax (mM) 28.763.05 129634.0*
AUC (mmol?h/L) 101611.4 199618.2*
Tmax (h) 0.2560 0.3160.063
T1/2 (h) 0.8660.26 0.5560.26
Concentration at 24 h (mM) 2.661.5 0.4660.28
Cmax: maximum concentration in plasma; AUC: area under the plasma
concentration–time curve; Tmax: time to maximum plasma concentration; T1/2:
half-life of flavonoid in the elimination phase.
Each flavonoid (50 mg/kg bw) was administered to mice once by stomach
intubation. Plasma concentration was analyzed by HPLC–UV. Data are the mean
6 S.E (n = 4). Asterisks indicate significant differences between two groups
(Cmax: p= 0.026; AUC: p= 0.0039, Student’s t-test).
doi:10.1371/journal.pone.0045048.t003
Figure 5. Plasma concentration of 8-PN or naringenin after
their oral administration in mice. Each flavonoid was orally
administered at 50 mg/kg bw in a single dose by stomach intubation.
The plasma concentration of each flavonoid was determined by HPLC–
UV after deconjugation treatment. Closed triangle: 8-PN, closed square:
naringenin. Data are the mean 6 S.E (n = 4).
doi:10.1371/journal.pone.0045048.g005
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content in the GM were much higher than those of naringenin
(Table 2). Enhancement of accumulation in muscle tissue is how
flavonoids exert preventive effects upon disuse muscle atrophy.
Several reports have shown that orally administered naringenin is
mostly metabolized into conjugated metabolites in intestinal
epithelial cells and hepatic cells before entering the blood
circulation, resulting in quite low (or undetectable) levels of its
aglycone in plasma [34,35,36]. In general, conjugation reactions
are known to diminish a wide variety of the biological activities of
flavonoids because conjugated metabolites are characterized as
hydrophilic, stable products to be excreted into urine [37]. One
study using quercetin indicated that all tissues (including muscle)
contained 30–100% of the deconjugated aglycone of total
flavonoids after long-term supplementation of quercetin to pigs
[38] even though the aglycone could have been derived from
deconjugation during the extraction procedure. In contrast,
neither the GM nor plasma accumulated naringenin in the
present study. Interestingly, herein we demonstrated that a
considerable amount of the 8-PN aglycone was present in the
plasma and GM. In particular, the content of the 8-PN aglycone
was almost identical to that of total naringenin in the GM
(Table 2). The ratio of the aglycone to total 8-PN in the GM was
0.15 without denervation and 0.17 with denervation, and was
nearly tenfold higher than that in the plasma (0.016). Therefore, it
is plausible that in situ deconjugation of 8-PN precedes its
accumulation in the GM for it to exert preventive effects. Some
authors have argued that deconjugation of dietary flavonoids must
occur for these compounds to exert their functions in vivo
[39,40,41]. Further studies are required to clarify the role of
deconjugation in the preventive effects of prenylated flavonoids.
We selected 8-PN for evaluation of the structural significance of
prenylation in dietary flavonoids for exertion of their physiological
functions. Binding of the prenyl group to the molecule should
accelerate intestinal absorption by passive diffusion because such
binding increases lipophilicity and allows the molecule to have a
higher affinity to cellular membranes [42]. High accumulation of
8-PN in muscle tissue and the appearance of preventive effects
may be derived from its high bioavailability based on effective
absorption in the intestine. However, the time-courses of the
plasma concentrations of 8-PN and naringenin in a single dose
(Figure 5) and their values of Cmax and AUC shown in Table 3
indicated that the prenylation of flavonoids lowered their
effectiveness with regard to intestinal absorption and blood
circulation. Pang et al. [43] reported that a prenylated chalcone
exhibits little efflux into the basolateral side when incorporated
into Caco-2 cells (a cellular model of intestinal absorption). It is
therefore likely that prenylation suppresses the intestinal absorp-
tion of flavonoids by interfering with efflux into the portal vein. In
contrast, the plasma concentration of total 8-PN 24 h after
administration was significantly higher than that seen with
naringenin (Table 3), indicating that prenylation reduces the rate
of elimination into urine. This may be why 8-PN was present in
plasma at a considerable level after its ingestion for 22 days
(Table 2). Our study on uptake using cultured mouse C2C12
myotubes (Figure 4) strongly suggested that prenylation signifi-
cantly enhanced the accumulation of flavonoids within cells and/
or their association to cellular membranes in mouse C2C12
myotubes because it increased passive transport into cells and
interaction with cellular membranes owing to increased lipophi-
licity. Therefore, prenylation seems to be an effective tool to
improve the physiological functions of dietary flavonoids by
increasing the concentration to target tissues through a reduction
in the rate of elimination from the circulation and higher uptake
into cells.
Results from studies on denervated mice demonstrated that 8-
PN suppressed atrogin-1 content in denervated muscle compared
with control-diet mice (Figure 2c). 8-PN is known to be a powerful
phytoestrogen [44,45,46]. Some studies suggest that estrogenic
status affects recovery from disuse muscle atrophy by accelerating
the Akt signaling pathway [22,23]. That is, estrogen deficiency
inhibits the reproduction of muscle, and estradiol supplementation
accelerates the regeneration of skeletal muscles. Our results clearly
indicated that 8-PN intake accelerated Akt phosphorylation
(Figure 2c). Taken together, the mechanism for 8-PN-dependent
prevention of muscle atrophy may be related to its estrogenic
activity, which can promote post-natal growth and delay the
degradation of skeletal muscles. Insulin-like growth factor-1
(IGF1)/phosphatidyl inositol 3-kinase (PI3K)/Akt pathway-medi-
ated phosphorylation of FoxOs by phosphorylated Akt causes their
exclusion from the nucleus, thereby preventing their transcription
activity [26,29]. It is therefore likely that 8-PN suppresses the
expression of atrogin-1 by inhibiting the transcription activity of
FoxOs by elevating the phosphorylated Akt level. 8-PN may also
induce protein synthesis because hypertrophy in skeletal muscle
was also shown to be activated by the IGF1/PI3K/Akt pathway
[47]. Further study is required to clarify exact mechanism for the
preventive effects of 8-PN on disused muscle atrophy.
8-PN is a demethylated metabolite of isoxanthohumol through
the CYP450 reaction in the liver [14]. This prenylated flavonoid
can also be produced from isoxanthohumol by the action of
microflora in the digestive tract [15,16] Isoxanthohumol is
produced from xanthohumol via a ring-closing reaction during
brewing [12,13]. Therefore, xanthohumol and isoxanthohumol
present in H. lupulus and beer can act as pro-8-PN. Stevens et al.
Figure 6. Preventive effect of Humulus lupulus on disuse muscle
atrophy. Mice consumed a Humulus lupulus-mixed diet for 14 days,
after which denervation was carried out. After 4 days, the weight of the
GM was measured. The level of atrophy was calculated to be the ratio of
the weight of denervated muscle to the weight of sham muscle in each
mouse. Data are the mean 6 S.E (n = 3). Asterisks indicate significant
differences analyzed by the Student’s t-test (P = 0.0046).
doi:10.1371/journal.pone.0045048.g006
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showed levels of isoxanthohumol and 8-PN in beer to be 40–
3,440 mg/L and 1–240 mg/L, respectively [12]. It has been shown
that, in healthy post-menopausal Caucasian women, nearly 25%
were moderate producers and 15% were strong producers of 8-PN
based on urinary excretion through microbial conversion capac-
ities [15]. A clinical study demonstrated that orally administered 8-
PN was absorbed rapidly at a very limited level and was associated
with decreased concentrations of luteinizing hormone in post-
menopausal women [36]. Therefore, diets or supplements
containing 8-PN (or an 8-PN precursor) could be beneficial for
human health. H. lupulus is known to contain isoxanthohumol and
8-PN at 0.1–1.0% [12]. The results regarding intake of H. lupulus
(Figure 6) could suggest the beneficial effects of H. lupulus on the
prevention of disuse muscle atrophy. Bolca et al. found that 8-PN
could accumulate in human breast tissue if 8-PN producers were
given H. lupulus for 5 days [48]. Our results in mice suggest that
daily consumption of 1150–1250 nmol 8-PN/kg bw/day (0.4 mg/
kg bw/day) is effective for the prevention of disuse muscle atrophy.
For an individual weighing 50 kg, this corresponds to daily
consumption of 1 kg dry weight of H. lupulus and 83–20,000 L of
beer. However, continuous consumption of 8-PN or its precursors
in food and beverages every day may lead to a gradual increase in
8-PN content in target tissues. It is likely that daily consumption of
foods or beverages containing 8-PN or its related compounds
could contribute to the prevention of disuse muscle atrophy,
although the study was limited to in model animal experiment
using denervated mouse.
In summary, prenylation enabled naringenin to prevent disuse
muscle atrophy in denervated mice. Prenylation also significantly
enhanced accumulation in target tissues. These findings strongly
suggest that prenylation of flavonoids induces their preventive
effects by increasing their contents in target tissues. Prenylation
seems to be a promising tool for developing and enhancing the
pharmacological and physiological functions of dietary flavonoids.
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